OssDsign

7 articles about OssDsign

• OssDsign Appoints VP of Sales for OssDsign USA, Inc to Drive Continued Growth in the Company's Largest Market

  5/6/2020

  OssDsign announces the appointment of Eric Patermo as VP of Sales for OssDsign USA, Inc, a wholly owned subsidiary of OssDsign AB.

• OssDsign Receives US FDA Clearance for Cranial PSI Accessories - Strengthening Business Position in the US

  10/14/2019

  OssDsign AB announced that the US Food and Drug Administration has granted 510 clearance to market OssDsign Cranial PSI Accessories in the US. The cleared products are a set of 3D-printed, patient specific accessory devices designed to support and expand clinical use of OssDsign's patient specific cranioplasty implant already cleared by the FDA.

• OssDsign AB (publ) Initiates Commercial Preparations for Launch in Japan Following Regulatory Filing for OssDsign Cranial

  8/9/2019

  OssDsign AB, the Swedish designer and manufacturer of innovative implants for bone regeneration, has filed for a Japanese regulatory approval of OssDsign Cranial.

• Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North

  2/12/2019

  Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million.

• OssDsign AB Raises 64 MSEK (6 MEUR) Through Private Placement and Initiates Preparations for Stock Exchange Listing

  2/12/2019

  OssDsign AB announced the closing of a private placement of 64 MSEK.

• OssDsign Announces Agreement For Distribution Of OSSDSIGN Cranial In The U.S.A. With Matador Medical Inc.

  2/2/2017

• OssDsign Announces FDA 510(k) Clearance of OSSDSIGN Cranial for Sale in the USA

  1/20/2017